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Abstract
Introduction: Primary pigmented nodular adrenocortical disease is a rare cause of adrenocorticotropic hormone-
independent Cushing’s syndrome. We report an uncommon primary pigmented nodular adrenocortical disease
case presenting with a unilateral adrenocortical nodule and provide a brief overview of the existing literature.
Case presentation: A 27-year-old Caucasian woman was admitted to our Department with adrenocorticotropic
hormone-independent Cushing’s syndrome. Its cause was initially considered a left adrenocortical adenoma based
on computer tomography imaging. The patient underwent left laparoscopic adrenalectomy and histological
examination revealed pigmented micronodular adrenal hyperplasia. Evaluation for the presence of Carney complex
was negative. Six months later recurrence of hypercortisolism was documented and a right laparoscopic
adrenalectomy was performed further establishing the diagnosis of primary pigmented nodular adrenocortical
disease. After a nine-year follow-up there is no evidence of residual disease.
Conclusions: Even though primary pigmented nodular adrenocortical disease is a rare cause of Cushing’s
syndrome, it should be included in the differential diagnosis of adrenocorticotropic hormone-independent
Cushing’s syndrome, especially because adrenal imaging can be misleading mimicking other adrenocortical
diseases. Bilateral laparoscopic adrenalectomy is the preferred treatment in these subjects.
Introduction
Primary pigmented nodular adrenocortical disease
(PPNAD) and adrenocorticotropic hormone (ACTH)-
independent macronodular adrenal hyperplasia
(AIMAH) account for approximately 10% of ACTH-
independent Cushing’s syndrome (CS) [1-3].
PPNAD is characterized by pigmented adrenocortical
nodules ranging in size from sub-microscopic to 10 mm
in diameter. The cortical nodules are unencapsulated
and appear black and brown containing large, globular
cells with pigment-laden, eosinophilic cytoplasm,
whereas the inter-nodular cortex is usually atrophic
[4-6].
Half of PPNAD patients appear to be sporadic cases
and the other half are familial, mostly associated with
Carney complex (CNC) [4,7,8].
PPNAD may manifest with typical signs of CS or pre-
sent with sub-clinical or cyclic CS [4,8]. The treatment
of choice in CS due to PPNAD is bilateral
adrenalectomy.
Case presentation
A 27-year-old Caucasian woman was referred to our
Surgery Department from the Endocrinology Depart-
ment for surgical treatment of ACTH-independent CS
considered to be caused by an adrenocortical adenoma.
The patient reported a three-year history of hirsutism,
acne, menstrual disturbances and mood disorders. On
clinical examination, skin atrophy, buffalo hump, moon
facies, proximal muscle weakness and elevated blood
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pressure (145/90 mmHg) were documented. Our
patient’s history and clinical signs were suggestive of
hypercortisolism and she was further evaluated.
Hormonal investigation revealed elevated morning cor-
tisol levels (702, reference range (RR): 130-690 nmol/L)
with suppressed ACTH levels (3.6, RR: 9-52 pg/mL), ele-
vated urinary free cortisol (UFC) levels (221, RR: 20-90
μg/24 h), loss of circadian rhythm of cortisol secretion
(plasma cortisol (16:00): 693 nmol/L, (00:00): 694: 694
nmol/L) and failure to suppress endogenous plasma cor-
tisol following low dose dexamethasone suppression test
(LDDST) (plasma cortisol after LDDST: 800 nmol/L)
(Table 1).
A 2 cm adenoma of the left adrenal gland was identi-
fied in the adrenal computerized tomography (CT) scan,
whereas the right adrenal appeared normal in size and
architecture.
The hormonal and radiological findings led to the
diagnosis of ACTH-independent CS due to an adreno-
cortical adenoma of the left adrenal gland and our
patient underwent left laparoscopic adrenalectomy. On
surgery, both adrenals had macroscopically a pigmented,
micronodular appearance (Figure 1). Histology revealed
adrenal hyperplasia with small, pigmented cortical
nodules establishing the diagnosis of PPNAD.
In order to exclude the presence of CNC, our patient
underwent a chest CT scan, pituitary magnetic reso-
nance imaging (MRI) scan, ultrasound (US) of the geni-
tals and heart, and all were unremarkable. Her family
history was negative.
Six months later recurrence of hypercortisolism was
documented and a right laparoscopic adrenalectomy was
performed. Histology confirmed the initial diagnosis of
pigmented micronodular adrenal hyperplasia.
Our patient’s post-operative course was uncomplicated
and she received replacement therapy with hydrocorti-
sone and fludrocortisone. On one-year follow-up, all
signs and symptoms of CS resolved and nine years later
there is no evidence of hypercortisolism or CNC.
Technical aspects of laparoscopic adrenalectomy
We prefer the trans-peritoneal lateral decubitus
approach as the best for maximal exposure of the gland
and adjacent organs and vessels. In the right, we use
three 10 mm trocars, introducing a fourth 5 mm at a
later stage. In the left, we use two 10 mm trocars and
two 5 mm trocars.
Right adrenalectomy
The right triangular ligament and the retroperitoneal
liver attachments are cauterized and divided in order to
allow liver retraction and expose the upper limits of the
adrenal gland. After dividing the retroperitoneum, the
inferior vena cava (IVC) is identified and dissected from
the gland. The periadrenal fat is gently pushed upwards
with endo-peanuts. The adrenal vein is subsequently
identified, dissected, double-clipped and divided. The
inferior and superior adrenal vessels are cauterized or
clipped. Ultrasonic scissors are used after the ligation of
the adrenal vein.
Left adrenalectomy
The left colonic flexure is occasionally mobilized and
the left upper renal pole is exposed. The splenic attach-
ments are cauterized and divided, and the tail of pan-
creas is identified. The spleen is further mobilized until
the stomach is visualized. Gerota’s fascia is then opened,
the adrenal gland identified and the adrenal vein dis-
sected, double clipped and divided. The upper adrenal
vessels are either cauterized or clipped.
The specimen is placed in a bag and extracted after
minimally extending the 10 mm port-site incision.
Discussion
We describe a PPNAD case presenting with a large cor-
tical nodule, mimicking a unilateral adrenocortical ade-
noma, thus illustrating the puzzling differential
diagnosis of ACTH-independent CS.
In PPNAD the adrenal glands are usually normal in
size, in some patients micronodules are visible and, even
Table 1 Hormonal investigation.
Plasma hormones Results Reference range
Cortisol 08:00: 702 Morning:130-690,
16:00: 693 Evening: 70-345 nmol/L
00:00: 694
ACTH 3.2 9-52 pg/ml
UFC 221 20-90 μg/24 h
Cortisol following LDDST 800 <50 nmol/L
Figure 1 Macroscopic pigmented micronodular appearance of
adrenal glands on surgery. Intra-operative view of the
hyperplastic nodular adrenal glands.
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rarer, one or more macronodules (>1 cm in diameter)
can be present uni- or bilaterally, making the differential
diagnosis from AIMAH very difficult [9]. Bilateral
uptake of iodocholesterol is demonstrated in cortical
adrenal scintigraphy in most subjects with PPNAD [6].
The imaging of a solitary cortical nodule on CT scan
with otherwise normal adrenal glands made the diagno-
sis of bilateral adrenocortical dysfunction remote and no
iodocholesterol scintigraphy was performed.
Even though our patient presented with typical signs
and symptoms of CS (central obesity, hirsutism, myopa-
thy, hypertension), the clinical picture of PPNAD may
also be subtle or cause cyclical CS, i.e. episodes of corti-
sol excess interspersed by periods of normal cortisol
secretion [4,8]. These atypical manifestations of the dis-
ease may lead to further delay in diagnosis and
treatment.
Patients with PPNAD fail to suppress cortisol by
LDDST and high dose dexamethasone suppression test
(HDDST) and the majority of them characteristically
respond with an increase of UFC by 100% or more
using the Liddle’s test (sequential LDDST and HDDST).
This test has been useful to differentiate PPNAD from
AIMAH or identify asymptomatic subjects with CNC
[10]. This delayed paradoxical response was associated
with an increased expression of the glucocorticoid
receptor (GR); its molecular basis still remains to be
clarified [11].
Once diagnosis of PPNAD was established histologi-
cally, our patient underwent evaluation for CNC, since
half of PPNAD cases are sporadic and the other half
familial, usually associated with CNC [4,7]. The latter is
a multiple endocrine neoplasia consisting of spotty skin
pigmentation, cardiac myxomas and endocrine over-
activity (mainly hypercortisolism and/or growth hor-
mone overproduction) [4,7,8]. PPNAD is observed in
25% of CNC subjects [4,7]. Almost 50% of CNC patients
are familial cases. One of the putative genetic loci,
mapped on chromosome 17q22-24, has been identified
as the type 1a regulatory subunit of cyclic adenosine
monophosphate (cAMP)-dependent protein kinase A
(PRKAR1a) [12-15]. PRKAR1a inactivating mutations
were found in approximately half of CNC kindreds [15].
Linkage analysis has also identified a putative genetic
locus at chromosome 2p16 [12,13]. Genetic testing was
not performed in our patient.
Recurrence of hypercortisolism six months post-
operatively led to completion of bilateral adrenalectomy
further supporting the diagnosis of PPNAD. Even
though there is a report of a PPNAD subject undergoing
unilateral adrenalectomy without recurrence of clinical
CS, the long-term follow-up of this patient demon-
strated abnormal cortisol secretion [16]; on the other
hand, there are follow-up studies, where subtotal or
unilateral adrenalectomy in some PPNAD cases resulted
in remission of hypercortisolism [6,17].
Bilateral adrenalectomy is the treatment of choice for
CS due to PPNAD. The laparoscopic approach is asso-
ciated with lower morbidity rate compared with the
open technique, less post-operative pain, shorter hospi-
talization time and lower overall cost.
On nine-year follow-up our patient has no clinical or
biochemical signs of CS, whereas periodic evaluation for
CNC remains negative.
Conclusions
Even though PPNAD, sporadic or familial, is a rare
cause of CS, it should be included in the differential
diagnosis of ACTH-independent CS, especially because
adrenal imaging can be misleading mimicking other
adrenocortical diseases. Every patient diagnosed with
PPNAD should be screened for CNC and monitored
closely on a long-term basis. Bilateral laparoscopic adre-
nalectomy is the preferred treatment in subjects with
PPNAD.
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